Personalized Psychiatry
ISSN: 2720-7048
Psychiatria Spersonalizowana / Personalized Psychiatry
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2025
vol. 4
 
Share:
Share:
abstract:
Case report

Integrated treatment of treatment-resistant depression – a case study of Ericksonian psychotherapy assisted by intravenous ketamine

Szymon Niemiec
1

  1. Pracownia E. Weatherwax Szymon Niemiec, Warszawa; E. Weatherwax Szymon Niemiec Workshop, Warsaw
Personalized Psychiatry 2025; 4: e76–e79
Online publish date: 2025/08/26
View full text Get citation
 
PlumX metrics:
The article presents a case study of a 22-year-old female patient suffering from severe, treatment-resistant depression who did not respond to standard pharmacological treatments and psychotherapy. An integrated, three-phase therapeutic model was implemented, combining Ericksonian psychotherapy with intravenous ketamine infusions. The treatment process included a preparatory phase, a series of 12 ketamine infusions, and a six-month integration therapy phase. In this approach, the altered state of consciousness induced by ketamine was utilized as a therapeutic trance, which facilitated bypassing the patient’s rigid cognitive patterns and accessing her unconscious resources. The therapy resulted in a significant and lasting reduction in symptoms of depression and anxiety, confirmed by both quantitative and qualitative analysis. The author concludes that the synergy between a biological intervention (ketamine) and psychotherapy, based on preparation, a catalytic intervention, and integration, represents a promising, personalized method for treating severe mental disorders.
keywords:

treatment-resistant depression, ketamine, Ericksonian psychotherapy, case study, integrated treatment

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.